Lenalidomide
ALDRICH/901558 - ≥95%
Synonym: 1-
CAS Number: 191732-72-6
Empirical Formula (Hill Notation): C13H13N3O3
Molecular Weight: 259.26
MDL Number: MFCD07772307
Linear Formula: C13H13N3O3
Product Type: Chemical
| assay | ≥95% |
| form | powder |
| InChI | 1S/C13H13N3O3/c14-9-3-1-2 |
| InChI key | GOTYRUGSSMKFNF-UHFFFAOYSA |
| ligand | lenalidomide |
| mp | 265-268 °C |
| reaction suitability | reagent type: ligand |
| SMILES string | O=C1N(C2CCC(NC2=O)=O)CC3= |
| storage temp. | 2-8°C |
| Application: | Lenalidomide is a ligand demonstrated to bind the Cereblon (CRBN) protein. Lenalidomide, along with other thalidomide derivatives, are useful for constructing small molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . Explore protein degrader building blocks , E3 ligase ligand-linker conjugates that simplify the synthesis and library generation of PROTACs.. |
| Legal Information: | PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license |
| Other Notes: | Technology Spotlight: Degrader Building Blocks for Targeted Protein Degradation ![]() Portal: Building PROTAC® Degraders for Targeted Protein Degradation ![]() Structure of the human Cereblon–DDB1–lenalidomid ![]() Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells ![]() The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins ![]() |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H361d - H373 |
| Precautionary statements | P201 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% |
| mp | 265-268 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352101 |

. Explore 